Breaking news and real-time updates from the ASX small-cap market
ASX slips for a third straight week as bets on another rate rise surge after the RBA warns inflation remains a threat; miners rally, banks and energy retreat.
Small Caps to cover AGC26 as official media partner at Australia's largest gold conference, spotlighting ASX gold plays as gold price steadies above $4,300/oz.
Memphasys nets exclusive Felix System deal with INVIDO LAB in Czech Republic, Slovakia, Kazakhstan; €416k min purchases, unlocking recurring cartridge revenue.
AdAlta's IRO platform earns commercial validation as Oribiotech inks a 10-year, up to US$120m deal to manufacture a marketed cell therapy in APAC.
Anson Resources completes environmental surveys for Yellow Cat ahead of Phase 2 drilling; targets maiden JORC resource as assays flow early next year.
Central Petroleum lifts FY26 revenue to $44.7m as Palm Valley PV14 drilling advances; multi-year gas contracts boost cash flow and margins.
Tesoro Gold unveils 1.28 Moz Ore Reserve at Ternera, Chile (42.8 Mt @ 0.93 g/t). NPV US$994m, IRR 57%, payback 17 months; El Zorro Feasibility under way.
Finbar Group starts Romeo Applecross construction after securing A$121.1m pre-sales (two-thirds sold); end value ~A$192m; completion targeted FY2029.
Prescient Therapeutics hits enrolment milestone: PTX-100 Phase 2a reaches 20 evaluable patients; first Dose Optimisation Committee review in December 2026.
Thrive Tribe initiates first substantive WooBoard CARE build for veterans, targeting physio/psych providers on Gold Coast/Brisbane/Ipswich.
Resonance Health signs 24-month deal with UK CRO Image Analysis to add SaMD MRI endpoints to global trials, targeting obesity and metabolic disease.
Viking Mines uncovers wide scheelite zones in maiden Linka RC drill, Nevada; 22m visible scheelite in 24m horizon; assays due Sept–Oct as drilling advances.
